RAPT Therapeutics (RAPT) Depreciation & Amortization (CF) (2020 - 2024)
Historic Depreciation & Amortization (CF) for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $287000.0.
- Therapeutics' Depreciation & Amortization (CF) fell 917.72% to $287000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.2 million, marking a year-over-year decrease of 123.36%. This contributed to the annual value of $1.2 million for FY2024, which is 106.91% down from last year.
- According to the latest figures from Q4 2024, Therapeutics' Depreciation & Amortization (CF) is $287000.0, which was down 917.72% from $300000.0 recorded in Q3 2024.
- In the past 5 years, Therapeutics' Depreciation & Amortization (CF) registered a high of $400000.0 during Q2 2020, and its lowest value of $199000.0 during Q1 2020.
- For the 5-year period, Therapeutics' Depreciation & Amortization (CF) averaged around $274300.0, with its median value being $300000.0 (2020).
- Examining YoY changes over the last 5 years, Therapeutics' Depreciation & Amortization (CF) showed a top increase of 5075.38% in 2021 and a maximum decrease of 5000.0% in 2021.
- Quarter analysis of 5 years shows Therapeutics' Depreciation & Amortization (CF) stood at $223000.0 in 2020, then fell by 10.31% to $200000.0 in 2021, then grew by 23.5% to $247000.0 in 2022, then rose by 27.94% to $316000.0 in 2023, then dropped by 9.18% to $287000.0 in 2024.
- Its last three reported values are $287000.0 in Q4 2024, $300000.0 for Q3 2024, and $300000.0 during Q2 2024.